Scarica l'app Stockscreener
0.6561
4.54%
0.0285
VolitionRX Ltd Borsa (VNRX) Ultime notizie
Is now a turning point for VolitionRx Limited2025 Price Targets & AI Driven Stock Movement Reports - Newser
Ranking VolitionRx Limited among high performing stocks via tools2025 Valuation Update & High Yield Stock Recommendations - Newser
How to read the order book for VolitionRx Limited2025 Buyback Activity & Target Return Focused Picks - Newser
Advanced analytics toolkit walkthrough for VolitionRx LimitedRisk Management & Community Consensus Stock Picks - Newser
D. Boral Capital Reiterates "Buy" Rating for VolitionRx (NYSE:VNRX) - MarketBeat
Long term hold vs stop loss in VolitionRx LimitedWeekly Loss Report & Precise Swing Trade Entry Alerts - Newser
Should you wait for a breakout in VolitionRx LimitedGap Down & Free Long-Term Investment Growth Plans - Newser
Is VolitionRx Limited stock poised for growth2025 Risk Factors & AI Enhanced Trade Execution Alerts - Newser
How to build a dashboard for VolitionRx Limited stockStop Loss & Precise Swing Trade Alerts - Newser
Will VolitionRx Limited see short term momentumM&A Rumor & Fast Entry High Yield Stock Tips - Newser
VolitionRX (NYSEAMERICAN:VNRX) Share Price Crosses Below 50 Day Moving AverageShould You Sell? - MarketBeat
VolitionRx : Short Corporate Deck, Sept 2025 - MarketScreener
VolitionRX (VNRX) Maintains "Buy" Rating with $5 Target Price | - GuruFocus
VolitionRx Partners with Werfen to Advance Diagnostic Testing for Antiphospholipid Syndrome - citybuzz -
VolitionRx (VNRX) Enters Agreement with Werfen for APS Research - GuruFocus
VolitionRx signs first human out licensing deal for APS - TipRanks
VolitionRx Limited stock momentum explained2025 Sector Review & AI Powered Market Entry Ideas - Newser
Volition Signs First Human Out Licensing Deal09.09.25News - Ariva
What institutional flow reveals about VolitionRx LimitedWeekly Profit Summary & Verified Entry Point Detection - Newser
Trend analysis for VolitionRx Limited this week2025 Volume Leaders & AI Powered Trade Plan Recommendations - Newser
What’s next for VolitionRx Limited stock price2025 Technical Patterns & Intraday High Probability Alerts - Newser
What is VolitionRx Limited’s book value per shareJuly 2025 Sentiment & Stock Portfolio Risk Control - خودرو بانک
VolitionRX (NYSEAMERICAN:VNRX) Stock Price Passes Below 50 Day Moving AverageHere's Why - MarketBeat
What risks could impact VolitionRx Limited stock performance2025 Big Picture & Safe Capital Growth Trade Ideas - Newser
Veterinary Oncology Market Shares, Competition and Trends - GlobeNewswire
VolitionRx Limited stock prediction for this weekQuarterly Trade Summary & Verified Short-Term Plans - Newser
Will VolitionRx Limited outperform tech stocksLayoff News & Daily Chart Pattern Signals - خودرو بانک
Price momentum metrics for VolitionRx Limited explained2025 Performance Recap & Growth-Oriented Investment Plans - Newser
What technical models suggest about VolitionRx Limited’s comeback2025 Historical Comparison & Entry Point Strategy Guides - Newser
VolitionRx Ltd. Earnings Call: Key Insights and Challenges, Cost Reduction, Revenue Growth, and Promising Clinical Study Outcomes Amid Uncertainty - AInvest
Combining machine learning predictions for VolitionRx Limited2025 Top Gainers & Daily Price Action Insights - Newser
How to forecast VolitionRx Limited trends using time series2025 Technical Patterns & Risk Controlled Swing Alerts - Newser
VolitionRx : Corporate Presentation September 2025 - MarketScreener
Can VolitionRx Limited rally from current levels2025 AllTime Highs & Free Reliable Trade Execution Plans - Newser
Zacks Small Cap Weighs in on VolitionRx Q3 Earnings - MarketBeat
Developing predictive dashboards with VolitionRx Limited dataTrade Exit Summary & High Accuracy Trade Alerts - Newser
VolitionRx Ltd. Earnings Call: Key Insights and Challenges - TipRanks
Using AI based signals to follow VolitionRx Limited2025 Major Catalysts & High Conviction Trade Alerts - Newser
What earnings revisions data tells us about VolitionRx LimitedTrade Volume Report & Real-Time Volume Trigger Notifications - Newser
What to do if you’re stuck in VolitionRx LimitedMarket Performance Report & Stock Portfolio Risk Control - Newser
Tools to monitor VolitionRx Limited recovery probabilityLong Setup & Weekly Watchlist of Top Performers - Newser
Should I add VolitionRx Limited stock to my portfolioDollar Strength & Weekly Top Stock Performers List - 선데이타임즈
Analyzing drawdowns of VolitionRx Limited with statistical toolsTrade Volume Report & Low Risk Growth Stock Ideas - Newser
2.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):